0001728117-23-000164.txt : 20231205
0001728117-23-000164.hdr.sgml : 20231205
20231205171224
ACCESSION NUMBER: 0001728117-23-000164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231204
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Robert Paul JR
CENTRAL INDEX KEY: 0002003059
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38796
FILM NUMBER: 231467530
MAIL ADDRESS:
STREET 1: C/O GOSSAMER BIO, INC.
STREET 2: 3013 SCIENCE PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gossamer Bio, Inc.
CENTRAL INDEX KEY: 0001728117
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 922-0718
MAIL ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wk-form4_1701814328.xml
FORM 4
X0508
4
2023-12-04
0
0001728117
Gossamer Bio, Inc.
GOSS
0002003059
Smith Robert Paul JR
3013 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
0
1
0
0
Chief Commercial Officer
0
Stock Option (Right to Buy)
0.969
2023-12-04
4
A
0
1500000
0
A
2033-12-03
Common Stock
1500000
1500000
D
25% of the total number of shares subject to the option will vest on December 4, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
/s/ Jeff Boerneke, Attorney-in-Fact
2023-12-05